Traws Pharma
TRAW
30 hedge funds and large institutions have $3.45M invested in Traws Pharma in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 9 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
3% more funds holding
Funds holding: 29 → 30 (+1)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
41% less capital invested
Capital invested by funds: $5.87M → $3.45M (-$2.42M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$548K |
| 2 |
VF
Virtu Financial
New York
|
+$291K |
| 3 |
HF
HRT Financial
New York
|
+$252K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$248K |
| 5 |
Squarepoint
New York
|
+$211K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$672K |
| 2 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$109K |
| 3 |
Barclays
London,
United Kingdom
|
-$65.3K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$59K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Renaissance Technologies
New York
| – | -$672K | -3,166 | Closed |
|
|
SAMH
27
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
| – | -$109K | -512 | Closed |
|
|
28
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$59K | -267 | Closed |
|
|
FIA
29
FNY Investment Advisers
New York
| – | -$56K | -267 | Closed |
|
|
30
Barclays
London,
United Kingdom
| – | -$65.3K | -264 | -99% |
|
|
EWA
31
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
| – | -$13K | -62 | Closed |
|
32
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$10K | -48 | Closed |
|
33
Cerity Partners
New York
| – | -$8K | -40 | Closed |
|
|
CAN
34
Cetera Advisor Networks
El Segundo,
California
| – | -$1K | -5 | Closed |
|
|
WCG
35
Weaver Consulting Group
Huntington Beach,
California
| – | +$247 | +1 | +100% |
|
36
Wells Fargo
San Francisco,
California
| – | +$494 | +2 | +200% |
|
TRAW Hedge Fund Activity: Q3 2020 in Review
30 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2020, worth a combined $3.45M — down 41% from $5.87M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TRAW positions and 9 closed out — a net gain of 1 holder — while 11 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $548K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $672K sold.
- 30 institutional investors held Traws Pharma (TRAW) as of Q3 2020, up from 29 in Q2 2020.
- Funds reported $3.45M of Traws Pharma stock for Q3 2020, down 41% quarter-over-quarter.
- 10 funds opened new Traws Pharma positions in Q3 2020 and 9 closed out, a net change of +1 holder.
- The largest Traws Pharma buyer in Q3 2020 was Vanguard Group, an estimated $548K added.
- The largest Traws Pharma seller in Q3 2020 was Renaissance Technologies, an estimated $672K sold.
Based on aggregated 13F filings for Q3 2020.